AIM
ARKG icon

ARK Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

ARK Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$69.8K Sell
1,659
-5,114
-76% -$163K ﹤0.01% 179
2026
Q1 		$179K Buy
6,773
+1,744
+35% +$51.1K ﹤0.01% 169
2025
Q4 		$146K Sell
5,029
-2,022
-29% -$60.7K ﹤0.01% 178
2025
Q3 		$196K Buy
7,051
+2,730
+63% +$69K ﹤0.01% 184
2025
Q2 		$105K Buy
4,321
+429
+11% +$9.4K ﹤0.01% 179
2025
Q1 		$80.8K Sell
3,892
-2,097
-35% -$52.7K ﹤0.01% 177
2024
Q4 		$141K Buy
5,989
+2,521
+73% +$62K ﹤0.01% 166
2024
Q3 		$88.8K Sell
3,468
-3,872
-53% -$98.6K ﹤0.01% 178
2024
Q2 		$172K Sell
7,340
-777
-10% -$19.6K ﹤0.01% 172
2024
Q1 		$233K Sell
8,117
-1,062
-12% -$31.9K ﹤0.01% 202
2023
Q4 		$301K Buy
9,179
+5,155
+128% +$140K ﹤0.01% 198
2023
Q3 		$112K Buy
4,024
+829
+26% +$27.1K ﹤0.01% 219
2023
Q2 		$109K Sell
3,195
-2,837
-47% -$89.2K ﹤0.01% 217
2023
Q1 		$181K Sell
6,032
-10,102
-63% -$313K ﹤0.01% 210
2022
Q4 		$455K Buy
16,134
+14,553
+920% +$462K ﹤0.01% 207
2022
Q3 		$52K Sell
1,581
-9,126
-85% -$335K ﹤0.01% 241
2022
Q2 		$345K Buy
10,707
+3,858
+56% +$135K ﹤0.01% 237
2022
Q1 		$315K Sell
6,849
-46,541
-87% -$2.22M ﹤0.01% 253
2021
Q4 		$3.27M Buy
53,390
+37,478
+236% +$2.59M 0.01% 203
2021
Q3 		$1.19M Buy
15,912
+7,521
+90% +$631K ﹤0.01% 257
2021
Q2 		$776K Sell
8,391
-2,344
-22% -$199K ﹤0.01% 256
2021
Q1 		$953K Buy
10,735
+9,065
+543% +$899K ﹤0.01% 257
2020
Q4 		$156K Buy
+1,670
New +$133K ﹤0.01% 234

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

ARK Investment Management's ARKG Position: Q2 2026 in Review

ARK Investment Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 76% in Q2 2026, selling an estimated $163K and leaving 1,659 shares worth $69.8K. The position accounts for ﹤0.01% of the portfolio, ranked #179.

ARK Investment Management first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.27M in Q4 2021. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • ARK Investment Management held 1,659 shares of ARK Genomic Revolution ETF worth $69.8K as of Q2 2026.
  • ARK Investment Management sold 5,114 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $163K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of ARK Investment Management's portfolio in Q2 2026, its #179 holding.
  • ARK Investment Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • ARK Investment Management's ARK Genomic Revolution ETF position peaked at $3.27M in Q4 2021.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on ARK Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.